Eli Lilly
Eli Lilly achieved exponential growth through breakthrough diabetes and obesity drugs demonstrating first-mover advantage in GLP-1 receptor agonists. Vertical integration spans drug discovery, clinical trials, and manufacturing.
Eli Lilly achieved exponential growth through breakthrough diabetes and obesity drugs demonstrating first-mover advantage in GLP-1 receptor agonists. Vertical integration spans drug discovery, clinical trials, and manufacturing.